(QDEC) First Trust Exchange - - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome

QDEC: Options, ETF, Index, Equity

The First Trust Exchange-Traded Fund VIII - FT Cboe Vest Growth-100 Buffer ETF - December (BATS:QDEC) is designed to provide a defined outcome investment strategy. Under normal market conditions, the fund allocates substantially all of its assets to FLEX Options, which are customizable equity or index option contracts. These options are tied to the performance of the Invesco QQQ TrustSM, Series 1 (QQQ), a widely followed ETF tracking the Nasdaq-100 Index. FLEX Options allow for tailored contract terms, including strike prices, styles, and expiration dates, offering flexibility in hedging and return enhancement strategies. The fund is non-diversified, meaning it may concentrate its investments in a limited number of securities, which can increase risk.

As a buffer ETF, QDEC aims to provide downside protection while participating in the upside of the underlying index, up to a predetermined cap. This structure is particularly appealing to investors seeking risk mitigation in volatile markets. The funds investment strategy involves buying and selling FLEX Options, which are exchange-traded and provide transparency in pricing. The use of FLEX Options allows the fund to target specific outcomes, such as limiting losses during market downturns while capturing a portion of the gains during upswings.

From a technical standpoint, QDEC is currently trading at $27.30, slightly below its 20-day SMA of $28.12 and 50-day SMA of $27.91. The 200-day SMA stands at $26.73, indicating that the fund is trading near its long-term average. The Average True Range (ATR) of 0.29 suggests relatively low volatility in recent trading sessions. The funds average 20-day volume is 163,784 shares, reflecting moderate liquidity.

Over the next three months, QDEC is expected to face headwinds as the 20-day and 50-day SMAs are currently above the funds price, indicating potential resistance levels. However, the 200-day SMA remains below the current price, suggesting long-term support. The low ATR indicates that volatility is likely to remain subdued, but investors should monitor for potential increases in volatility as market conditions evolve. The funds AUM of $578.42 million underscores its popularity among investors seeking defined outcome strategies.

Additional Sources for QDEC ETF

QDEC ETF Overview

Market Cap in USD 527m
Category Defined Outcome
TER 0.90%
IPO / Inception 2020-12-18

QDEC ETF Ratings

Growth 5y 57.6%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -2.25
Analysts -
Fair Price Momentum 24.73 USD
Fair Price DCF -

QDEC Dividends

No Dividends Paid

QDEC Growth Ratios

Growth Correlation 3m -4.7%
Growth Correlation 12m 91.9%
Growth Correlation 5y 68.6%
CAGR 5y 6.70%
CAGR/Max DD 5y 0.27
Sharpe Ratio 12m 1.60
Alpha -1.00
Beta 0.65
Volatility 24.79%
Current Volume 45.3k
Average Volume 20d 45.2k
What is the price of QDEC stocks?
As of March 14, 2025, the stock is trading at USD 26.06 with a total of 45,300 shares traded.
Over the past week, the price has changed by -3.05%, over one month by -8.43%, over three months by -5.75% and over the past year by +5.81%.
Is First Trust Exchange - a good stock to buy?
Partly, yes. Based on ValueRay Analyses, First Trust Exchange - (BATS:QDEC) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.58 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QDEC as of March 2025 is 24.73. This means that QDEC is currently overvalued and has a potential downside of -5.1%.
Is QDEC a buy, sell or hold?
First Trust Exchange - has no consensus analysts rating.
What are the forecast for QDEC stock price target?
According to ValueRays Forecast Model, QDEC First Trust Exchange - will be worth about 27.2 in March 2026. The stock is currently trading at 26.06. This means that the stock has a potential upside of +4.41%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 27.2 4.4%